SCHEMBL9201848

SCHEMBL9201848

O=C1CC(c2cc3cc(Br)ccc3o2)CN1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.41
GRIN1 Q05586 1/20 0.40
GRIN2A Q12879 1/20 0.40
GRIN2B Q13224 1/20 0.40
GRIN2C Q14957 1/20 0.40
GPR35 Q9HC97 1/20 0.40
PIM1 P11309 2/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
MAOA P21397 1/20 0.40
NPC1 O15118 5/20 0.39
RAB9A P51151 5/20 0.39
ALDH1A1 P00352 4/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM5 P08912 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9202060 0.83 CA12 (0.40) CA12CA1CA2CA9ALDH1A1
SCHEMBL9200232 0.83 MAOB (0.45) GPR35CA12CA1CA2CA9
SCHEMBL9315800 0.83 ALDH1A1 (0.43) CA12CA1CA2CA9MAOA
SCHEMBL9195715 0.81 ACHE (0.55) NPC1RAB9AALDH1A1CYP1A2CYP2C19
SCHEMBL9315026 0.80 ACHE (0.41) CA12CA2CA9ALDH1A1CYP1A2
SCHEMBL9315699 0.80 PIM1 (0.44) PIM1MAOAALDH1A1CYP1A2CYP2C19
SCHEMBL9197524 0.80 TSHR (0.39) ALDH1A1CYP1A2CYP2C19MTNR1ALMNA
SCHEMBL9316757 0.76 PDE4A (0.38) ALDH1A1CYP1A2CYP2C19MTNR1APDE4A
SCHEMBL10902517 0.74 BCHE (0.65) CYP2A6GRIN1GRIN2AGRIN2BGRIN2C
SCHEMBL9201839 0.71 MTNR1A (0.40) PIM1ALDH1A1CYP1A2CYP2C19MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0463969-B1 New compounds of 4-aminobutyric acid, process for their preparation and pharmaceutical preparations containing them ADIR (FR) 1995-02-08 EP disclosed
US-5278166-A 4-amino-3-heteroaryl butyric acid compounds, compositions, and their use for treating disorders involving a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1994-01-11 US disclosed
US-5214063-A 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1993-05-25 US disclosed
US-5162364-A Treatment of spastic and senescence disorders ADIR ET COMPAGNIE (FR) 1992-11-10 US disclosed
EP-0463969-A1 New compounds of 4-aminobutyric acid, process for their preparation and pharmaceutical preparations containing them ADIR ET COMPAGNIE (FR) 1992-01-02 EP disclosed